Comparison of the five models on experimental hyperlipidemia rats

Chinese Pharmacological Bulletin

Volumn 23, Issue 9, 2007, Pages 1254-1256

  Zhang, Dong ^a   Wu, Hai Jun ^a   Chen, Shi Ping ^a   Ying, Kang ^a   Yang, Yu Mei ^a  

^a BAOTOU MEDICAL COLLEGE   (China)

Author keywords

Hyperlipidemia; Make model; Rat

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EMULSION; HYPERLIPIDEMIA; LIPID METABOLISM; NONHUMAN; PRESCRIPTION; RAT;

EID: 37049010961     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Zhang X M, Wei X B, Wu B J. The choosing of regulating lipid-drug and antiatherosclerotic drugs[M]//Xu S Y, Bian R L, Chen X ed. Methodologyof Pharmacological Experiment. 3th ed. Beijing; People's medical publishing house, 2001:1201-6.
2. Zhao S P, Wu J. The influences of fenofibrate on levels of tum or necrsis factor-alpha in serum and adipocytes secretion of hypercholesterolemia rabbits[J]. Chin Pharmacol Bull, 2005,21(2):157-61.
3. Ni H C, Li J, Jin Y, et al. The experimental animal model of hyperlipidemia and hyperlipidemic fatty liver in rats[J]. Chin Pharmacol Bull, 2004,20(6):703-6.
4. Zhang Q H, Sun W J. Effects of Yiqi Huoxue prescription on rat lipid metabolism and NO level [J]. Chin J Exp Tradit Med Formul, 2003,9(1):19-21.
5. Wang Z Y, Wang I, Pan Z W, et al. Effects of amiodarone on potassium currents in rat remodeling ventricular myocytes after myocardial infarction[J]. Chin Pharmaco Bull, 2005,21(12):1451-4.